Journey Medical Corporation (DERM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.96
-0.81%
Mkt Cap $184.86M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$11.75
Range $10.50 – $13.00
Implied Upside
+136.9%
Consensus $11.75 vs current $4.96